Whitepaper: Cubis® II Pharma Compliant by Design
Sartorius’ Cubis® II balance series offers customisable modularity to ensure compliance with FDA directive 21 CFR Part II and EU Annex 11. This whitepaper outlines details of the technical solutions that will enable companies to achieve full compliance.
The Cubis® II balance series was designed for customisable modularity, which means the user can choose from many hardware and software options for thousands of different configurations. Choose from among 45 weighing modules, seven draft shields, two display and control units, and five software packages, including more than 60 software apps.
Related content from this organisation
- Pharmaceutical membrane filtration market to value $10 billion by 2025
- Cell line development services market to value $2.4 billion by 2030
- Microbial air sampler market to value $545mn by 2028
- Pharmaceutical QC market to value $9,700mn by 2027
- ebook: Important considerations for every bio-pharmaceutical microbiology QC lab